Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.


home / news releases / AXGT - Axovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day

AXGT - Axovant to Participate in Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day

Axovant Gene Therapies Ltd.

NEW YORK and BASEL, Switzerland, March 31, 2020 (GLOBE NEWSWIRE) -- Axovant Gene Therapies Ltd. (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies for neurological diseases, today announced that management will participate in the virtual Guggenheim Healthcare Talks: Genomic Medicines and Rare Disease Day on Friday, April 3, 2020.

About Axovant

Axovant Gene Therapies is a clinical-stage company focused on developing a pipeline of innovative gene therapy product candidates for debilitating neurological diseases. The company's current pipeline of gene therapy candidates targets GM1 gangliosidosis, GM2 gangliosidosis (including Tay-Sachs disease and Sandhoff disease), and Parkinson’s disease. Axovant is focused on accelerating product candidates into and through clinical trials with a team of experts in gene therapy development and through external partnerships with leading gene therapy organizations.

Media and Investor Contact:

Parag Meswani
Axovant Gene Therapies
(212) 547-2523
investors@axovant.com
media@axovant.com
Stock Information
Company Name: Axovant Gene Therapies Ltd.
Stock Symbol: AXGT
Market: NYSE
Menu
AXGT AXGT Quote AXGT Short AXGT News AXGT Articles AXGT Message Board
Get AXGT Alerts

News, Short Squeeze, Breakout and More Instantly...